Janux Therapeutics, Inc.

Derivative exercise · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

insider.option_exercise

Occurred

2026-07-08

Reported

2026-07-10

Disclosure lag

2 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	Janux Therapeutics, Inc.
Source	SEC EDGAR ↗
Source identifier	0001864158-26-000004
Event ID	#2412

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001864158-26-000004",
  "acquired_disposed": "D",
  "code": "M",
  "direct_or_indirect": "D",
  "form": "4",
  "is_derivative": true,
  "issuer_name": "Janux Therapeutics, Inc.",
  "label": "Exercise of derivative",
  "person_name": "Campbell David Alan",
  "price": 0,
  "role": "Director, President and CEO",
  "security": "Stock Option (right to buy)",
  "shares": 7000,
  "shares_owned_after": 697550,
  "source_path": "edgar/data/1864158/0001864158-26-000004.txt",
  "ticker": "JANX",
  "value": null
}

Source: Open recorded SEC filing

Source: SEC EDGAR · as of 2026-07-10T00:00:00Z